Sirtuin 1 Inhibiting Thiocyanates (S1th)—A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sirtuin 1 Inhibiting Thiocyanates (S1th)—A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-30
DOI
10.3389/fonc.2020.00657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
- (2019) Débora Kristina Alves-Fernandes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial–mesenchymal transition in ovarian carcinoma
- (2019) Tong Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions
- (2018) Dina Robaa et al. CHEMICAL RECORD
- Recent advances in inhibitors of sirtuin1/2: an update and perspective
- (2018) Ziyan Zhou et al. Future Medicinal Chemistry
- Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells
- (2018) Jalal Choupani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sirtuin activators and inhibitors: Promises, achievements, and challenges
- (2018) Han Dai et al. PHARMACOLOGY & THERAPEUTICS
- New chemical tools for probing activity and inhibition of the NAD + -dependent lysine deacylase sirtuin 2
- (2018) Sören Swyter et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
- (2018) María Paula Ceballos et al. TOXICOLOGY LETTERS
- SIRT1 promotes formation of breast cancer through modulating Akt activity
- (2018) Xiaoxia Jin et al. Journal of Cancer
- Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
- (2018) Tomohiro Kozako et al. BMC CANCER
- Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities
- (2018) Nicole A. Spiegelman et al. ChemMedChem
- Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage
- (2018) Stuart G. Jarrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a cellularly active SIRT6 allosteric activator
- (2018) Zhimin Huang et al. Nature Chemical Biology
- Rational design and synthesis of reversible covalent PPARγ antagonistic ligands inhibiting Ser273 phosphorylation
- (2018) Hyunsoo Kim et al. Asian Journal of Organic Chemistry
- Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
- (2018) Khaldoun Rifaï et al. Cancers
- Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
- (2017) Antonia Cagnetta et al. HAEMATOLOGICA
- The role of SIRT6 in tumors
- (2017) Vanessa Desantis et al. HAEMATOLOGICA
- Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity
- (2017) Sébastien Moniot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
- (2017) Matthias Schiedel et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current State of NAD+ -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
- (2017) Matthias Schiedel et al. MEDICINAL RESEARCH REVIEWS
- The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
- (2017) Changwen Wang et al. Oncotarget
- Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
- (2017) Antonia Cagnetta et al. HAEMATOLOGICA
- The role of SIRT6 in tumors
- (2017) Vanessa Desantis et al. HAEMATOLOGICA
- SIRT1 Enhances the Survival of Human Embryonic Stem Cells by Promoting DNA Repair
- (2017) Jiho Jang et al. Stem Cell Reports
- Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity
- (2016) Asad Ali Shah et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL)
- (2016) Savita Bhalla et al. CANCER BIOLOGY & THERAPY
- A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
- (2016) Hui Jing et al. CANCER CELL
- SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway
- (2016) L.-K. Ran et al. CLINICAL CANCER RESEARCH
- Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure–Activity Relationship Study
- (2016) Matthias Schiedel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sirtuin functions and modulation: from chemistry to the clinic
- (2016) Vincenzo Carafa et al. Clinical Epigenetics
- The Role of SIRT1 in Cancer
- (2015) Melissa J. Wilking et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of Sirt1 Promotes Prostatic Intraepithelial Neoplasia, Reduces Mitophagy, and Delays Park2 Translocation to Mitochondria
- (2015) Gabriele Di Sante et al. AMERICAN JOURNAL OF PATHOLOGY
- An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
- (2015) Sigurd D. Süssmuth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target
- (2015) Ryoichi Asaka et al. LABORATORY INVESTIGATION
- Selectivity hot-spots of sirtuin catalytic cores
- (2015) Marco Daniele Parenti et al. Molecular BioSystems
- Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells
- (2015) Sapna Singh et al. TUMOR BIOLOGY
- Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
- (2015) Tobias Rumpf et al. Nature Communications
- Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease Recurrence
- (2014) Q. Long et al. CANCER RESEARCH
- Sirtuin deacetylases: A new target for melanoma management
- (2014) Melissa J Wilking et al. CELL CYCLE
- Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols
- (2014) Lucie Ryckewaert et al. TOXICOLOGY LETTERS
- Histone deacetylase SIRT1 modulates and deacetylates DNA base excision repair enzyme thymine DNA glycosylase
- (2013) Amrita Madabushi et al. BIOCHEMICAL JOURNAL
- Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization
- (2013) Anton Simeonov Expert Opinion on Drug Discovery
- The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
- (2013) L. Serrano et al. GENES & DEVELOPMENT
- The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD+) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition
- (2013) Xun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases
- (2013) Reggy Ekkebus et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: Implications for neurodegenerative diseases
- (2012) Veronika Seiberlich et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Thermodynamic studies for drug design and screening
- (2012) Nichola C Garbett et al. Expert Opinion on Drug Discovery
- Sirtuins as regulators of metabolism and healthspan
- (2012) Riekelt H. Houtkooper et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibitors of the NAD+-Dependent Protein Desuccinylase and Demalonylase Sirt5
- (2012) Benjamin Maurer et al. ACS Medicinal Chemistry Letters
- Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
- (2011) Mikael Altun et al. CHEMISTRY & BIOLOGY
- SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
- (2010) Barrie Peck et al. MOLECULAR CANCER THERAPEUTICS
- Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
- (2009) Emily Ho et al. JOURNAL OF NUTRITION
- A Quantitative Model of Thermal Stabilization and Destabilization of Proteins by Ligands
- (2008) Piotras Cimmperman et al. BIOPHYSICAL JOURNAL
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
- (2008) Rui-Hong Wang et al. CANCER CELL
- SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
- (2008) Philipp Oberdoerffer et al. CELL
- The Sirtuin family: therapeutic targets to treat diseases of aging
- (2008) Jill C Milne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now